Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Liofilchem s.r.l. · Predicate Candidate Screening

35 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

62 daysmedian FDA review time
99 days90th percentile
35clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K260696MTS Gepotidacin 0.016-256 µg/mLLiofilchem s.r.l.2026-04-17450
K252114MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mLLiofilchem s.r.l.2025-10-02870
K251580MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)Liofilchem s.r.l.2025-08-20890
K243202MTS Ceftobiprole 0.002-32 µg/mLLiofilchem s.r.l.2025-01-301210
K230479ComASP Cefiderocol 0.008-128Liofilchem s.r.l.2023-05-18850
K211672MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mLLiofilchem s.r.l.2021-10-201410
K200180MTS Omadacycline 0.002 - 32 ug/mLLiofilchem s.r.l.2020-03-20560
K192345MTS Ampicillin-Sulbactam 0.016/0.008 - 256/128 µg/mLLiofilchem s.r.l.2019-10-31630
K191908MTS Imipenem 0.016-256 µg/mLLiofilchem s.r.l.2019-09-04500
K191809MTS Imipenem-relebactam 0.002/4-32/4 µg/mLLiofilchem s.r.l.2019-08-23490
K190914MTS Doxycycline 0.016 - 256 µg/mLLiofilchem s.r.l.2019-05-29510
K190252MTS Gentamicin 0.016 - 256 µg/mLLiofilchem s.r.l.2019-03-22430
K183527MTS Ciprofloxacin 0.002 - 32 µg/mLLiofilchem s.r.l.2019-03-19900
K183140MTS Tetracycline 0.016 - 256 ug/mLLiofilchem s.r.l.2019-01-11590
K183115MTS Levofloxacin 0.002 - 32 µg/mLLiofilchem s.r.l.2018-12-20410
K182922MTS Omadacycline 0.002-32 µg/mLLiofilchem s.r.l.2018-12-14560
K182557MTS Eravacycline 0.002 - 32 µg/mLLiofilchem s.r.l.2018-11-02460
K181889MTS Penicillin 0.002- 32 µg/mLLiofilchem s.r.l.2018-09-13620
K181708MTS Plazomicin 0.016-256 µg/mLLiofilchem s.r.l.2018-07-31330
K180886Liofilchem MIC Test Strip (MTS), Delafloxacin 0.002 - 32 ug/Liofilchem s.r.l.2018-05-18440
K180339Liofilchem MIC Test Strip (MTS), Azithromycin 0.016 - 256 µgLiofilchem s.r.l.2018-04-04560
K180330Liofilchem MIC Test Strip (MTS)- Linezolid 0.016 - 256ug/mLLiofilchem s.r.l.2018-03-15370
K173817Liofilchem MIC Test Strip (MTS), Ceftazidime-avibactam 0.016Liofilchem s.r.l.2018-02-28750
K173307Liofilchem MIC Test Strip (MTS), Meropenem/vaborbactam 0.016Liofilchem s.r.l.2017-12-19620
K172542Liofilchem MIC Test Strip (MTS)- Tedizolid 0.002 - 32 mg/mL.Liofilchem s.r.l.2017-10-23610
K172109Liofilchem MIC Test Strip (MTS), Erythromycin 0.016 - 256 µgLiofilchem s.r.l.2017-09-27760
K171906Liofilchem MIC Test Strip (MTS)- Delafloxacin 0.002 - 32 µg/Liofilchem s.r.l.2017-08-01360
K170772Liofilchem MIC Test Strip (MTS)- Clindamycin 0.016 - 256 µg/Liofilchem s.r.l.2017-06-07850
K170892Liofilchem MIC Test Strip (MTS)- Tedizolid 0.002 - 32 µg/mLLiofilchem s.r.l.2017-05-25590
K163517Liofilchem MIC Test Strip (MTS) Telavancin 0.016 - 256.0 µg/Liofilchem s.r.l.2017-03-14890
K163298Liofilchem MIC Test Strip (MTS) Ceftazidime 0.016 - 256.0 µgLiofilchem s.r.l.2017-02-22920
K162854Liofilchem MIC Test Strip (MTS) Meropenem 0.002-32.0 ug/mlLiofilchem s.r.l.2016-12-19680
K161175Liofilchem MIC Test Strip (MTS)- Ceftolozane/Tazobactam 0.01Liofilchem s.r.l.2016-07-12770
K153569Liofilchem MIC Test Strip (MTS) -Dalbavancin at 0.002 - 32 uLiofilchem s.r.l.2016-06-221900
K153687Liofilchem MIC Test Strip (MTS)-Vancomycin 0.016 -256 ug/mLLiofilchem s.r.l.2016-03-31990

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda